Updated
Divergent Paths
Entered this position a few months ago when it broke 6 and sold at 7, looking for another entry point. Long bias due to decreasing short interest from the high of 42 M to 36 M, days to cover is currently at 23 from the May figure. There is a pending announcement of updated results of its Phase 1 drug used in Recurrent Glioblastoma. Hypothesis is that a positive reaction to the news will result in another attempt at the 8 dollar resistance level confirmation will come from a positive movement over the next few days and a decrease in the short interest when it is next reported. A negative reaction will result in a strengthening in the short interest and a decrease in price levels to longer (monthly) support levels. Next week will be a tipping point week and one to watch. Will likely enter a long position at 6.05 with an exit the next day if the price does not remain above 6 the day after the position is entered.
Note
Additionally the open interest is greater for the July 21st out of the money Calls than the out of the money Puts at a ratio around 13:4, Call:Put
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.